MSMarta Salek

Marta Salek

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marta Salek has a total of 223 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Quality Indicators in End‐of‐Life Care for Children With Cancer in Low‐ and Middle‐Income Countries

    by Michael J. McNeil, Ximena Garcia Quintero, Marta Salek, Asya Agulnik, Julia Downing, Veronica Dussel, Paola Friedrich, Wendy Gomez Garcia, Emily E. Johnston, Narine Movsisyan, et al.

    Background: Around 90% of children with cancer live in low‐ and middle‐income countries (LMICs), with the majority dying of their disease. Despite the need for quality end‐of‐life (EoL) care in LMICs, access and integration remain limited. Quality indicators (QIs) can assess and provide standards for high‐quality care. The aim of this study was to develop QIs for EoL care for children diagnosed with cancer in LMICs. Methods: The QIs were identified and prioritized through a multi‐phase process: (1) literature review identified potential QIs from existing guidelines, standards, and published studies; (2) modified Delphi approach engaged global experts to assess the importance and feasibility of QIs; and (3) prioritization conducted using a Discrete Choice Experiment (DCE) with experts and dot voting prioritization exercise with bereaved family members. Results: From the literature review, 73 potential QIs were identified. Fifty‐six global experts from 27 countries participated in the modified Delphi. Sixty‐four indicators across seven domains were deemed important with 25 identified as both important and feasible. Forty‐one global experts from 23 countries participated in the DCE prioritization and 12 bereaved family members from nine countries participated in the dot voting prioritization. While experts and family members prioritized some indicators similarly (i.e., symptom management), family members placed higher priority on QIs addressing communication and anticipatory guidance. Conclusion: This study describes a robust, context‐specific process which identified QIs for pediatric EoL care in LMICs. Future efforts will pilot and refine the QIs to demonstrate feasibility, sustainability, and impact on care quality. Precis: This study assessed potential quality indicators (QIs) for pediatric end‐of‐life (EoL) care in low‐ and middle‐income countries (LMICs) through a multi‐phase process involving global experts and bereaved families. The findings provide a set of potential QIs to evaluate and improve EoL care for children with cancer in LMICs.

  • Open Access

    Mapping the de-implementation of traditional diagnostic tests in pediatric acute lymphoblastic leukemia

    by Marta Salek, Kenneth Busby, Nathaniel Webb, Dylan E. Graetz, Charles G. Mullighan, Thomas B. Alexander, Nickhill Bhakta, Megan C. Roberts, Lu Wang

    Introduction: Advances in cancer diagnostics raise questions about when and how to de-implement traditional approaches; however, these processes remain poorly described. At St. Jude Children’s Research Hospital (SJCRH), routine conventional cytogenetics for pediatric acute lymphoblastic leukemia (ALL) diagnosis was de-implemented in 2018 following adoption of clinical genomics. This study aimed to map this process to inform future diagnostic de-implementation initiatives. Methods: Interviews were conducted with SJCRH staff involved or impacted by cytogenetics de-implementation. Data were analyzed using thematic and rapid qualitative analysis informed by the Consolidated Framework for Implementation Research. Member-checking was used to verify and refine process maps, which were subsequently reviewed by an external expert panel, representing diverse settings, through focus group discussions. Results: Thirteen SJCRH clinicians participated. De-implementation was described as successful, with no negative impact on patient outcomes. Decision-making began with internal correlation studies that demonstrated superior diagnostic performance of clinical genomics. De-implementation was viewed as a natural evolution that improved molecular classification, resource allocation, and workflow efficiency. Perceived risks included loss of cytogenetics competency, delayed turnaround time, and career insecurity, all addressed institutionally. Lessons learned highlighted the importance of deliberate discussion about logic and evidence supporting de-implementation. Fifteen external experts offered suggestions to improve process map generalizability, highlighting institutional- and system-level considerations. Conclusion: De-implementation of cytogenetics in ALL in favor of clinical genomics was successful at SJCRH. This study offers an example of diagnostic de-implementation in cancer care and proposes a structured approach to guide future efforts. De-implementation should be considered alongside introduction of novel diagnostic approaches.

  • Paediatric palliative care and paediatric euthanasia

    by Marta Salek, Julia Downing, Hazel M Gutiérrez, Erin Kwolek, Gayatri Palat, Megan Doherty

  • Transfusion Use Among Children With Hematologic Malignancies Receiving Concurrent Hospice Care

    by Meaghann S. Weaver, Rachel Jalfon, Jia Liang, Tricia Mamer, Liza-Marie Johnson, Erica C. Kaye, Marta Salek, Brittany Cowfer, Alexandra Superdock, Yimei Li, et al.


  • Open Access

    Physician Perceptions Toward Palliative Care Integration in Childhood Cancer Care in Asia Pacific

    by Marta Salek, Andrea Cuviello, Sri Andini Handayani, Sally Blair, Anjali Chandra, Godwin Job, Bella S. Ehrlich, Lee Ai Chong, Poonam Bagai, Ong Gek Bee, et al.

    PURPOSE: Palliative care (PC) integration in pediatric oncology improves outcomes, yet access to PC in the Asia Pacific (AP) region remains limited. This study aimed to understand physician perceptions of PC integration in childhood cancer care across AP. METHODS: The validated Assessing Doctors' Attitudes on Palliative Treatment survey was modified for use in AP, translated into six languages, and adapted for cultural relevance. The survey was distributed electronically between February 2022 and February 2024 to physicians caring for children with cancer in 18 AP countries. The primary outcome was alignment with WHO PC guidance, calculated as a mean percentage per physician. Secondary analyses explored associations between demographic variables and WHO alignment scores using regression analyses. Open-ended responses were analyzed qualitatively. RESULTS: A total of 621 physicians from 18 countries participated (median country response rate 30%; range, 11%-85% per country). Most (70%; n = 432) had >10 years of clinical experience and no prior PC training (65%; n = 401). Although 57% (n = 352) had access to pediatric PC experts, only 50% (n = 308), 36% (n = 221), 27% (n = 166), and 34% (n = 209) expressed comfort addressing patient/family physical, emotional, spiritual, and grief/bereavement needs, respectively. Additionally, 40% (n = 248) reported feeling burdened addressing end-of-life suffering. The mean alignment with WHO guidance was 76% (range, 48%-92%). Almost all (>90%; n = 570) desired further PC training. CONCLUSION: Study findings demonstrate that most physicians in AP expressed discomfort with providing core components of PC to patients with cancer and their families. This study signals the urgent need for focused expansion of PC services and training and identifies regional opportunities to improve PC education, research, and advocacy efforts.


  • Open Access

    Barriers to Palliative Care Integration for Children With Cancer Across Asia Pacific

    by Andrea Cuviello, Marta Salek, Sri Andini Handayani, Sally Blair, Anjali Chandra, Godwin Job, Bella S. Ehrlich, Lynna Chandra, Ross Drake, Sanjeeva Gunasekera, et al.

    PURPOSE: Early integration of palliative care (PC) for children with cancer is vital to improved patient outcomes. Despite this, access to PC services for children in Asia Pacific (AP) is sparce. We aimed to explore potential barriers to PC provision in childhood cancer care across AP. METHODS: The Assessing Doctors' Attitudes on Palliative Treatment survey was revised for cultural context, translated into six languages, and distributed electronically to physicians who care for children with cancer. Descriptive statistics were used to summarize data. Secondary analyses used the Pearson chi-square test or Fisher exact test to examine associations between prior PC training and physician subspecialty with reported barriers. The McNemar test was applied to evaluate differences between actual versus ideal timing of PC consultations. Analysis of variance was conducted to compare mean values for perceived barriers across country income levels. RESULTS: Six hundred twenty-one physicians from 18 countries participated, with an overall response rate of 27% (621/2,305) and a median country response rate of 30% (range, 11%-85%). Most respondents (n = 366; 59%) believed PC should be consulted at diagnosis, but only 18% (n = 117) stated that this occurred in their clinical setting ( P < .001). The most highly ranked barriers to PC provision included limited physician knowledge (n = 511; 82%), lack of national health policy/advocacy (n = 494; 79%), lack of PC-trained clinicians (n = 492; 79%), lack of home-based services (n = 487; 78%), and physician discomfort in discussing PC (n = 483; 78%). Physicians practicing in lower-middle–income countries rated these barriers more significantly. CONCLUSION: Physicians report a discrepancy between ideal and actual timing of PC integration and identify several barriers to PC provision. Study findings will inform capacity building, education, and advocacy initiatives to improve the timing and quality of PC delivery in the region.


  • Open Access

    Treatment Decision Making at Diagnosis for Children Presenting With Advanced Cancer in Low- and Middle-Income Countries

    by Marta Salek, Ana Caceres-Serrano, Joanne Canedo, Lucia Fuentes, Shoshana Mehler, Alaina Rule, Jamie Zeal, Carlos Rodriguez-Galindo, Dylan Graetz, Nickhill Bhakta, et al.

    PURPOSE: Although most children diagnosed with cancer live in low- and middle-income countries (LMICs), research exploring decision making in these settings remains sparse. When children present with advanced cancer in LMICs, local centers may lack resources to provide treatment required to achieve cure. Existing treatment guidelines often do not account for contextual and resource variations influencing decision making. This qualitative study sought to understand physician approaches to treatment decision making for children presenting with advanced cancer at diagnosis in LMICs. METHODS: Semistructured interviews were conducted with 36 physicians caring for children with cancer across all world regions and representing diverse income levels. Interviews were conducted in English, audio-recorded, and transcribed. Inductive content analysis focused on decision-making approaches. RESULTS: Most participants were female (n = 24; 67%), older than 36 years (n = 32; 89%), and practiced at centers caring for >100 new childhood cancer cases annually (n = 26; 72%) in lower-middle–income countries (n = 20; 55%). A spectrum of cancers were reported as advanced at diagnosis, with no single diagnosis predominating. Physicians generally recommended four treatment approaches (eg, curative-intent, non–curative-intent, referral, or limited chemotherapy trial), resulting in seven outcome pathways based on whether a family accepted, challenged, or declined the proposed treatment. Four decision-making approaches (eg, physician-led, family-led, participatory, or externally influenced) informed determinations of goals of care focused on optimizing prognostic outcomes, providing individualized care, and committing to treating all children, irrespective of differences in patient/family circumstances. CONCLUSION: Physicians caring for children with cancer in LMICs navigate complex treatment decision making, considering diverse treatment paths and goals. Pragmatic, evidence-based interventions are needed to guide decision making, flexible to local constraints.

  • Pediatric ALL Treatment Modifications in Low- and Middle-Income Countries: A Systematic Review

    by Caitlyn Duffy, Savannah Allen, Thomas B. Alexander, Eden C. Andrew, Manoo Bhakta, Nancy S. Bolous, Miguel Bonilla, Lisa M. Force, Catherine Habashy, Jeremy Hassan, et al.

    PURPOSE: For children with ALL in low- and middle-income countries (LMICs), treatment regimen adaptation based on local contexts is often necessary. However, the clinical impact of such modifications is poorly understood. The purpose of this study is to examine pediatric ALL treatment regimens used in LMICs, assess for patterns in adaptation to identify common barriers affecting global delivery of ALL care, and describe the breadth of outcomes. METHODS: Using the PRISMA guidelines, a systematic review was conducted, across seven databases, of ALL regimens use in LMICs in 2000-2021, documenting the geographic distribution of treatment backbone adoption, regimen modifications, and outcomes. Article characteristics were summarized using descriptive statistics. RESULTS: Of 13,900 articles, 125 met abstraction criteria. Data spanned 36 countries (6.4% low-income, 43.2% lower-middle–income, 50.4% upper-middle–income) and 163 regimens, of which 138 (84.6%) referenced a high-income ALL collaborative group regimen as a backbone. Sixty-four percent of regimens (n = 104) were adapted. Individual modifications (n = 390) were consolidated into 73 distinct regimen changes; reduction/omission of high-dose methotrexate, observed in 30 modified regimens (28.8%), was the most common. Implementation challenges, such as drug access and cost, were cited more frequently than toxicity as the rationale for modification; however, implementation outcomes (eg, feasibility, cost) were only measured in 6.4% of articles. Across all outcomes, 5-year overall survival was higher with modified versus unmodified regimens ( P = .030). CONCLUSION: Although implementation barriers are primary drivers of ALL regimen adaptations globally, the paucity of reported implementation outcomes represents a methodological gap in the literature. Incorporating implementation science methods and frameworks is critical for the timely and effective delivery of innovative treatment regimens across resource settings.


  • Preparing Adolescents and Equipping Parents for End-of-Life Care Preventing and Mitigating Moral Dilemmas

    by Meaghann S. Weaver, Erica Kaye, Liza M. Johnson, Marta Salek, Lori Wiener

  • Open Access

    Evacuating Patients With Pediatric Cancer From Ukraine: Impact on Medical Care Capacity in Poland

    by Aleksandra Oszer, Khrystyna Kliuchkivska, Julia Kołodrubiec, Andriy Sopilnyak, Marta Salek, Marcin W. Włodarski, Małgorzata Dutkiewicz, Zuzanna Nowicka, Maryna Krawczuk-Rybak, Jan Styczyński, et al.

    PURPOSE: Soon after the Russian invasion of Ukraine in February 2022, an initiative was organized to evacuate Ukrainian children with cancer, most initially to Poland. This study assessed the impact of this rapid increase in clinical need on the Polish system of pediatric cancer care. METHODS: This multicenter longitudinal approach was performed among all 19 Polish Pediatric Oncology Centers (PPOCs). We compared PPOC capacity before the invasion with that during the first 11 weeks after the invasion, using three ratios: patients to physicians (PtP), patients to nurses (PtN), and patients to beds (PtB). In addition, we used national data from an ongoing leukemia clinical trial to assess differences between the two study periods in the time required to comply with protocol-indicated medical procedures requiring general anesthesia. RESULTS: During the study period, 237 Ukrainian refugee children with cancer were treated in PPOCs; 60% of them arrived during the first 21 days of the war. The relative increase in patients varied significantly among the PPOCs, ranging from 42% to 460%. The average PtP, PtN, and PtB ratios increased significantly by 85%, 131%, and 105%, respectively. The portion of patients experiencing a delay in obtaining medical procedures requiring general anesthesia increased from 15% before the war to 18.2% ( P = .043). CONCLUSION: Because of the large number of Ukrainian children with cancer were evacuated to Poland, capacity of PPOCs was reduced, affecting cancer care for all patients. Maintaining standards of pediatric oncology care in Poland would not be possible without further patient referral to medical facilities around the world by international humanitarian collaborative action.